Typically, your provider will start you at 2.5 mg weekly and increase your tirzepatide dosage every four weeks until you reach a maintenance dose that is effective for you
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity or overweight with weight-related comorbidities
These decisions should be individualized based on your health needs and breastfeeding goals
Concerns about whether tirzepatide "shrinks your heart" lack scientific foundation based on current clinical evidence
Get it wrong, and you are either underdosing yourself or, worse, taking double what you should
Our tirzepatide niacinamide guide explains why pharmacies include this additive and what, if any, clinical effect it produces